PHRR230512-005700
LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) (ELEVATE)
A Randomized Double-blind, Four-Arm Active and Placebo-controlled Dose-Finding Trial to Evaluate the Efficacy, Tolerability, Safety and Dose Response of LYT-100 in Patients with Idiopathic Pulmonary Fibrosis (IPF)
PureTech·Phase 2·Philippine Health Research RegistryOngoing
Study focus
- Disease/Condition
- Idiopathic Pulmonary Fibrosis
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- PureTech
Timeline & enrollment
- Phase
- Phase 2
- Start date
- Feb 17, 2023
- End date
- N/A
ICD-10 classifications
Other interstitial pulmonary diseases with fibrosisCystic fibrosis with pulmonary manifestationsCystic fibrosisGraphite fibrosis (of lung)Pulmonary heart disease, unspecified
Data source
- Registry
- Philippine Health Research Registry
- Trial ID
- PHRR230512-005700
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for PHRR230512-005700 through Pure Global AI's free database. This Phase 2 trial is sponsored by PureTech and is currently Ongoing. The study focuses on Idiopathic Pulmonary Fibrosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Philippine Health Research Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.